NDC 68071-3976-06 - Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3976
- Requested NDC
- 68071-3976-06
- Package NDCs from labels
- 68071-3976-6, 68071-3976-8, 68071-3976-06
- Manufacturer
- NuCare Pharmaceuticals, Inc.
- Effective date
- 2026-09-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride - NuCare Pharmaceuticals, Inc. | NuCare Pharmaceuticals, Inc. | 2026-09-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3976-6 | Metformin Hydrochloride | 60 in 1 BOTTLE | TABLET, COATED | 60 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 056072d8-6228-4914-831d-ee7c0661b742 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 7078da8f-f8a7-411f-aa79-8a9710d0cdb5 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | f59ceea4-a84a-4082-8e73-7c6f340c28d6 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Apotex Corp. | 950613e2-e959-6b57-e172-251ddc53c64c | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Granules Pharmaceuticals Inc. | a5980bc8-8de8-c456-e053-2a95a90a792e | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | ef77c7dd-a65f-4adc-a0d9-a93779b459a0 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Golden State Medical Supply, Inc. | f86bda10-8b25-4125-8bb1-1b5917969ff0 | 2026-09-30 | Boxed warning, Warnings, Adverse reactions | 861007 861010 861004 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Laurus Labs Limited | c3dfa8a1-d10a-4a1a-8eba-5f4e2a5a2949 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | 861007 861010 861004 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | GLENMARK PHARMACEUTICALS INC., USA | 0ef9de1a-b786-4b6c-a250-3f5ac532b16a | 2026-09-23 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glipizide and Metformin Hydrochloride | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 3f2599c6-9e33-487e-9379-6477bb121461 | 2026-09-22 | Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE ER | METFORMIN HYDROCHLORIDE | Leading Pharma, LLC | 3dca884d-ec44-496f-9eeb-31fd8fa3f574 | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Ascend Laboratories, LLC | a944a167-e3ac-4084-af1c-22b48713471c | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 014f2a32-8440-4d0c-8f5d-c4b3a49e0dec | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 23aa50c5-28fe-4322-b5c6-1f1c48409b16 | 2026-09-21 | Boxed warning, Warnings, Adverse reactions | 861007 861010 861004 786Z46389E |
| Dapagliflozin and Metformin Hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | bddc2d47-8d3d-4c2f-8e5c-7a1a0782219a | 2026-09-17 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 4d4021ba-4b28-6b81-e063-6294a90a5ea7 | 2026-09-17 | Boxed warning, Warnings, Adverse reactions | ANDA205096 68071-3976-6 68071-3976-8 68071-3976 68071397606 861004 5bb05537-fa46-9fd4-e063-6294a90a6a01 4d4021ba-4b28-6b81-e063-6294a90a5ea7 786Z46389E |
| Dapagliflozin and Metformin Hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 7d575ca8-9c1f-469d-a341-34daf2f036dd | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 5ba1c159-5e1d-68ab-e063-6294a90a9139 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 861007 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 2737f784-07ad-4e5a-862f-beaea31d005e | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone and metformin hydrochloride | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 5ff2cd9e-a579-48f5-845f-c37a68372a34 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.